German Pharma Firm ITM Weighs Sale of Manufacturing Unit

ITM Isotope Technologies Munich SE, a German biotech firm specializing in radiopharmaceuticals, is in discussions on a potential sale of its medical isotope production business, according to people familiar with the matter.

The company has been working with advisers on the possible transaction and is in talks with several private equity firms, said the people, who asked not to be identified as the information is private. The manufacturing business has an earnings before interest, taxes, depreciation and amortization of about €60 million, they added.